APREPITANT
| Brand name | EMEND |
|---|---|
| Active ingredient | APREPITANT |
| Strength | 125MG |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | March 2003 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8258132 | September 2027 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.